0001735726-26-000001.txt : 20261008 0001735726-26-000001.hdr.sgml : 20261008 20261008113937 ACCESSION NUMBER: 0001735726-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261008 DATE AS OF CHANGE: 20261008 EFFECTIVENESS DATE: 20261008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoNano Medicine, Inc. CENTRAL INDEX KEY: 0001735726 ORGANIZATION NAME: EIN: 811713330 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-600468 FILM NUMBER: 261448909 BUSINESS ADDRESS: STREET 1: 550 RESERVE STREET STREET 2: SUITE 190 CITY: SOUTHLAKE STATE: TX ZIP: 76092 BUSINESS PHONE: (682) 712-1581 MAIL ADDRESS: STREET 1: 550 RESERVE STREET STREET 2: SUITE 190 CITY: SOUTHLAKE STATE: TX ZIP: 76092 D 1 primary_doc.xml X0708 D LIVE 0001735726 OncoNano Medicine, Inc. 3060 Pegasus Park Drive Dallas TX TEXAS 75247 682-285-1411 DELAWARE None None Corporation true Brent Sorrells 3060 Pegasus Park Drive Dallas TX TEXAS 75247 Executive Officer Brett Giroir 3060 Pegasus Park Drive Dallas TX TEXAS 75247 Executive Officer Director John Dyett 3060 Pegasus Park Drive Dallas TX TEXAS 75247 Director Gina Jones 3060 Pegasus Park Drive Dallas TX TEXAS 75247 Director Yumin Qui 3060 Pegasus Park Drive Dallas TX TEXAS 75247 Director Biotechnology Decline to Disclose 06b false 2026-09-23 false true false 0 Salem Partners LLC 43363 None None 11111 Santa Monica Blvd., Suite 2250 Los Angeles CA CALIFORNIA 90025 CA CALIFORNIA OH OHIO TX TEXAS false 15000000 10051615 4948385 false 14 402065 true 0 The broker earned $402,065 in cash and will earn a (1) 4.0% cash fee on any later sales and (2) warrant to purchase shares of common stock equal to 4% of the aggregate number of shares sold in the transaction. 0 false OncoNano Medicine, Inc. Brett P. Giroir Brett P. Giroir Interim CEO/Chairman 2026-10-01